SCHEMBL26093875

SCHEMBL26093875

O=Cc1ccc(CNC(=O)O)nc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ P4HTM Q9NXG6 1/20 0.37
▸ NPC1 O15118 3/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ POLB P06746 3/20 0.36
▸ GAA P10253 1/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ LMNA P02545 2/20 0.35
▸ HPGD P15428 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19555318 0.79 ESR1 (0.41) ALDH1A1KMT2AKDM4EMEN1SMN1; SMN2
SCHEMBL22581561 0.79 ADORA2A (0.47) KMT2ASMN1; SMN2NPC1RAB9AHPGD
SCHEMBL18041383 0.79 FTO (0.42) ALDH1A1KMT2AKDM4EMEN1SMN1; SMN2
SCHEMBL30419628 0.77 L3MBTL1 (0.43) KDM4ESMN1; SMN2NPC1RAB9APOLB
SCHEMBL6369210 0.77 L3MBTL1 (0.43) KDM4ESMN1; SMN2NPC1RAB9APOLB
SCHEMBL2099046 0.77 KDM4E (0.47) ALDH1A1KMT2AKDM4ESMN1; SMN2NPC1
SCHEMBL15173772 0.77 ADORA2A (0.44) KMT2ASMN1; SMN2P4HTMNPC1RAB9A
SCHEMBL691856 0.75 NPC1 (0.43) ALDH1A1KMT2AKDM4EMEN1SMN1; SMN2
SCHEMBL2843471 0.75 LMNA (0.54) SMN1; SMN2NPC1RAB9APOLBLMNA
SCHEMBL1935484 0.74 EPHX2 (0.55) ALDH1A1KMT2AMEN1SMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023067353-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER ARTIOS PHARMA LIMITED (GB) 2023-04-27 — — WO disclosed
Send feedback